InvestorsHub Logo
Followers 17
Posts 735
Boards Moderated 0
Alias Born 02/05/2004

Re: None

Sunday, 07/05/2015 3:15:03 PM

Sunday, July 05, 2015 3:15:03 PM

Post# of 345700
COVER STORY: Dallas vs. Houston: In the medical research funding race, UT Southwestern doing its part

Some of those success stories include Citracal, a calcium supplement for prevention of osteoporosis marketed by Mission Pharmacal, as well as Tenectaplase, a clot-busting drug marketed by Genentech under the trade name TNKase, Fitz said. UT Southwestern researchers also are credited with having done the biological research that led to cholesterol-lowering medications Zocor, Mevacor and Lipitor. The school’s research was instrumental in Peregrine Pharmaceuticals, a biopharmaceutical company focused on advancing bavituximab, an antibody designed for the treatment of cancers and viral infections.

http://www.bizjournals.com/dallas/print-edition/2015/03/20/cover-story-dallas-vs-houston-in-the-medical.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News